Welcome to our dedicated page for Capstone Holding news (Ticker: CAPS), a resource for investors and traders seeking the latest updates and insights on Capstone Holding stock.
Capstone Holding Corp (CAPS) delivers innovative solutions through its biotechnology research and construction materials distribution. This news hub provides investors with timely updates across both sectors, from clinical trial progress to market expansions.
Access authoritative reporting on key developments including peptide drug research for cardiovascular conditions and natural stone product innovations through subsidiary TotalStone, LLC. The page consolidates earnings reports, regulatory milestones, and strategic corporate actions.
Key coverage areas: FDA-designated drug trials, construction material launches, financial disclosures, and governance updates. Bookmark this page for comprehensive tracking of CAPS' progress in developing life-saving therapies while maintaining leadership in sustainable building solutions.
Capstone Holding Corp. (NASDAQ:CAPS) has announced its strategic expansion plans targeting the Southeast U.S. market, where it has identified over 1,500 potential acquisition candidates in the building products distribution sector.
In response to current economic challenges including persistent inflation and high interest rates, the company sees a strategic opportunity for growth through M&A activities. CEO Matt Lipman emphasizes that Capstone's Instone platform provides the necessary scale, infrastructure, and operational discipline needed in the current market environment.
The company is actively engaging in discussions with potential partners in the Southeast region, where their team already has an established presence. Capstone positions itself as a partner that can help building products distribution companies grow, adapt, and maintain their legacy through strategic partnerships.
Capstone Holding Corp. (NASDAQ:CAPS) reported strong Q4 2024 performance with revenue growth exceeding 8% year-over-year. The company has set an ambitious target of reaching a $100 million revenue run rate and $10 million Adjusted Instone EBITDA by end of 2025.
Key operational highlights include the successful launch of Toro Stone across 6 new states with 90 display installations and over 50 customer orders. The company completed targeted cost reduction initiatives and achieved improved gross margins.
Capstone's 2025 acquisition strategy focuses on Tuck-In Acquisitions, Sister Companies, and Platform Acquisitions, with deal multiples ranging from 4-6x EBITDA. The company plans to structure acquisitions with 20%-45% non-cash consideration.
Capstone Holding Corp (NASDAQ:CAPS) reports that while facing increased tariffs on Chinese imports, the company has experienced offsetting benefits from reduced container shipping costs. Container prices from China to the USA have dropped by 15% to 25% since the start of the year.
According to Instone CEO Kevin Grotke, the 10% tariff typically results in only a 3-4% price increase to customers, as tariffs apply solely to product costs, not freight. The decrease in shipping costs effectively neutralizes the current tariff impact.
Capstone Holding CEO Matt Lipman expressed confidence in the company's adaptable supply chain, which has proven resilient through previous challenges. Despite economic concerns, the company anticipates a strong 2025, citing factors such as declining interest rates, addressing housing shortages, and continued remodeling expenditures.
Capstone Holding Corp (NASDAQ:CAPS) reports over 30% growth in thin brick veneer products at its Instone business compared to the previous year. The company has launched a new product line called 'Linear Brick' under the Toro Stone brand, inspired by Italian architectural heritage and available in three distinct palettes.
The thin brick market has shown significant growth over the past five years, with the adhered veneer segment emerging as the fastest-growing category due to its installation ease and cost-effectiveness. The new Linear Brick product line aims to combine traditional craftsmanship with modern design elements, targeting the growing architectural products market.
Capstone Holding Corp. (OTCQB:CAPS) announced key leadership changes effective December 2, 2024. Michael Toporek has resigned as CEO while maintaining his position as Chairman of the Board. The Board has elected Matthew Lipman, a current director, to serve as CEO, President, and Secretary. Edward Schultz will continue his role as Chief Financial Officer, Vice President, and Treasurer.
Capstone Holding Corp. reinstated a Tax Benefit Plan, declaring a dividend distribution of one Right for each outstanding share of common stock to shareholders of record as of May 1, 2024. Each Right entitles the holder to purchase Series A Preferred Stock at an exercise price of $5. The Board aims to protect the Company's Tax Benefits through the Benefit Plan until April 1, 2027.
Capstone Therapeutics Corp. held its Annual Meeting on March 2, 2023, primarily to elect three Class III Directors and ratify the appointment of GBQ Partners, LLC as its independent accounting firm. BP Peptides, LLC, a majority shareholder, holds 77.26% of outstanding shares and facilitated the meeting through written consent, allowing the election of John M. Holliman, III, Matthew E. Lipman, and Frederic J. Feldman until 2026. GBQ Partners was ratified for the fiscal years ending December 31, 2022, and 2023. Capstone has shifted its focus from biotechnology to managing TotalStone, LLC, a construction materials company, following the discontinuation of its drug development business.
FAQ
What is the current stock price of Capstone Holding (CAPS)?
What is the market cap of Capstone Holding (CAPS)?
